Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$17814.0.

  • Neuraxis' Change in Receivables rose 8050.58% to -$17814.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $42348.0, marking a year-over-year increase of 21223.66%. This contributed to the annual value of $178845.0 for FY2024, which is 33547.42% up from last year.
  • According to the latest figures from Q3 2025, Neuraxis' Change in Receivables is -$17814.0, which was up 8050.58% from -$115190.0 recorded in Q2 2025.
  • Over the past 5 years, Neuraxis' Change in Receivables peaked at $185299.0 during Q1 2023, and registered a low of -$169135.0 during Q4 2022.
  • For the 4-year period, Neuraxis' Change in Receivables averaged around -$6475.5, with its median value being -$17814.0 (2025).
  • Per our database at Business Quant, Neuraxis' Change in Receivables surged by 53722.28% in 2024 and then tumbled by 28294.87% in 2025.
  • Quarter analysis of 4 years shows Neuraxis' Change in Receivables stood at -$169135.0 in 2022, then skyrocketed by 76.16% to -$40314.0 in 2023, then surged by 537.22% to $176262.0 in 2024, then plummeted by 110.11% to -$17814.0 in 2025.
  • Its Change in Receivables stands at -$17814.0 for Q3 2025, versus -$115190.0 for Q2 2025 and -$910.0 for Q1 2025.